New Evidence Found for CRP as an Independent Marker for Heart Diseas...( A new study ...),Health

A new study published in the New England Journal of Medicine lends further importance to the screening of C-reactive protein (CRP) in the detection of heart disease and stroke risk. Life Line Screening provides CRP screening along with glucose and cholesterol screenings.

Cleveland, OH (PRWeb) November 17, 2008 -- New clinical evidence indicates that a measurement called high-sensitivity C-reactive protein (CRP) is an independent marker that can pinpoint those at risk for stroke or heart attack even when cholesterol measurements are normal. Life Line Screening, the nation's leading provider of community-based preventive health screenings, includes testing for this risk indicator among its services.

Healthcare professionals traditionally view high levels of low-density lipoprotein (LDL) or "bad cholesterol" as the primary blood measurement for stroke and heart disease risk.

"Attention to CRP should not be avoided, as the new study in the NEJM indicates," states Andrew Manganaro, MD, FACS, FACC, Chief Medical Officer of Life Line Screening. "The results of this study shed light on the fact that half of all cardiovascular events occur in people without high cholesterol. The need to screen for other potential risk indicators is clear, and the medical community is beginning to explore this fact. We are proud to be able to offer the CRP screening along with our other testing services."

CRP is a marker of inflammation in the body. Previous studies suggested that its significance for ca
'/>"/>